Web Agent - Monitor small-cap companies listed on the Nasdaq or NYSE within emerging technological sectors that have experienced a significant surge in stock price over the past 3-6 months. Identify and collect recent news, press releases, analyst reports, and any other publicly available web data that could explain the rapid price appreciation. Focus on companies with market capitalizations below $2 billion.
Exscientia (NASDAQ: EXAI) shares have surged 105% over the past three months, following the July 8, 2026, announcement of a successful Phase 1b trial completion for its AI--designed oncology candidate, "EXS--4318." The trial demonstrated superior target engagement and a favorable safety profile compared to current standards of care. Analysts attribute the price appreciation to the company's transition from a platform--discovery model to a clinical--stage powerhouse, bolstered by a new $200 million milestone payment from its partnership with a top--ten global pharmaceutical firm.